29 de junio, 2022 – 15:00-16:15 CEST

Kids webinar advo toolkit SP landscape

La Federación Internacional de Diabetes (FID) estima que más de 1.200.000 niños y adolescentes viven con diabetes tipo 1. La diabetes tipo 2 también puede convertirse en un problema de salud pública en este grupo de edad, debido al aumento en los índices de obesidad y sedentarismo. Promover un entorno escolar que combata el estigma relacionado con la diabetes e incluya hábitos saludables para abordar los factores de riesgo prevenibles de la diabetes tipo 2 es fundamental para proteger la salud y la prosperidad de nuestras sociedades.

El 29 de junio (15:00-16:15 CEST) la FID organizó un webinario para presentar la Guía de Incidencia Política del proyecto Niños y Diabetes en las Escuelas (KiDS, por sus siglas en inglés) y discutir con varios experimentados defensores de personas con diabetes sobre cómo animar a los decisores locales y nacionales a mejorar la educación sobre la diabetes en las escuelas.

Este webinario fue moderado por el Dr. Douglas Villarroel, Presidente de la región de América del Sur y Central de la FID. Los panelistas en este webinario fueron:

  • Beatriz Yáñez Jiménez, Oficina Ejecutiva de la FID (España)
  • Elisabeth Morzadec, Oficina Ejecutiva de la FID (Francia)
  • Diana Novelo, Joven Líder en Diabetes de la FID (México)
  • Estefanía Malassisi, Joven Líder en Diabetes de la FID (Argentina)
  • Bruno Carrattini, Joven Líder en Diabetes de la FID (Uruguay)
  • Mariana Gómez, Blue Circle Voice de la FID (México)
  • Roxana Vizcaino, Blue Circle Voice de la FID (Ecuador)

Puede consultar la agenda del webinario aquí

Descargue las diapositivas aquí

Vea la grabación del webinario: 

Date: May 18, 13:00-14:30 CEST

WHO pre webinar landscape 01

The International Diabetes Federation (IDF) hosted an online event featuring a global panel of experts that looked at the potential of the WHO Global Diabetes Compact and the new WHO diabetes coverage targets to improve the lives of people living with diabetes.

Despite recent global efforts to tackle the diabetes pandemic, the number of people living with diabetes continues to rise – reaching 537 million in 2021. The projections are stark, with most countries off-track to achieve the WHO target of a 0% increase in diabetes prevalence by 2025.

To accelerate progress on diabetes and other NCDs, WHO has developed the Global Diabetes Compact with the vision of reducing the impact of diabetes and ensuring that all people with the condition have access to equitable, comprehensive, affordable and quality treatment and care. A core component of the Compact will be the new set of diabetes coverage targets that will be voted on at the 75th World Health Assembly (23-29 May, 2022).

  • Target 1: 80% of people with diabetes are diagnosed
  • Target 2: 80% of people diagnosed have a good control of glycaemia
  • Target 3: 80% of people diagnosed have a good control of blood pressure
  • Target 4: 60% of people with diabetes over 40 years or older receive statins
  • Target 5: 100% of people with type 1 diabetes have access to affordable insulin treatment and blood glucose self-monitoring

This online event was moderated by Ms Bridget McNulty, a diabetes advocate and IDF Blue Circle Voice from South Africa.

Speakers included:

  • Mrs Kazi Zebunnesa Begum, Additional Secretary (WH), HSD, Bangladesh Ministry of Health and Family Welfare
  • Prof Stephen Colagiuri, IDF Vice-president
  • Dr Bente Mikkelsen, Director, WHO NCDs department
  • Dr Slim Slama, Unit Head, WHO, NCD Management-Screening, Diagnosis and Treatment unit
  • Ms Leanne Riley, WHO, Head of the Surveillance, Monitoring and Reporting Unit, NCD department
  • Prof Edward Gregg, School of Public Health, Imperial College London
  • Prof João Raposo, Associação Protectora dos Diabéticos de Portugal
  • Ms Emma Klatman, Global Advocacy and Policy Manager, Life for a Child

Download the webinar agenda, the speaker biographies and the slides 

Access the recording below: 

If you have any questions about this webinar, please send them to This email address is being protected from spambots. You need JavaScript enabled to view it..

Cardiovascular and kidney disease are the two most common and life-threatening complications of type 2 diabetes (T2D). However, global data on prevalence, quality of care and outcomes for people living with these complications are not widely available.

Diabetes and diabetes complications registries can help deliver better care, decrease healthcare expenditure and save lives. Registries also facilitate epidemiological research that helps to identify trends and inform campaigns to bring about policy change to improve the lives of people living with diabetes.

The absence of registries and epidemiological data on T2D diabetes and cardio-renal complications is particularly apparent in low- and middle-income countries. To address the shortfall, IDF has initiated the T2D and cardio-renal complications programme. The initiative aims to:

  • Put diabetes registries in the hands of healthcare professionals (HCPs) in low- and middle-income countries.
  • Advocate for policies that improve quality of care.
  • Raise awareness of the risk and potential consequences of cardio-renal complications in people living with diabetes.

IDF invites HCPs to join the iCaReMe registry, a real-world, evidence-based international observational study that collects data on cardio-renal complications in people with type 2 diabetes. The registry provides a cloud-based tool for healthcare professionals to track data and follow up on their patients with diabetes and cardio-renal complications.

To be eligible for inclusion in the study, patients must meet the following criteria:

  • Be over 18 years of age.
  • Have type 2 diabetes and cardio-renal complications (heart failure, chronic kidney disease).
  • Provide written informed consent of their willingness to participate in the study.

For more information on the T2D and cardio-renal complications programme, including access to the registry and advice on how to participate in the study, please contact This email address is being protected from spambots. You need JavaScript enabled to view it..

iCaReMe logo   1

The International Diabetes Federation expresses its unanimous outrage at the ongoing situation in Ukraine and unreservedly condemns the act of aggression visited on the people of Ukraine by Russian forces. We are extremely concerned for people living with diabetes in Ukraine or displaced as a consequence of the unprovoked war.

The bombing of Ukraine, including the attacks on civilians and the bombing of hospitals has severely disrupted care for people with chronic diseases, including the more than 2.3 million people estimated to have been living with diabetes in the country before the invasion.

With widespread damage to infrastructure, people face drug shortages or difficulties in reaching distribution points. Damage to medical facilities will severely hinder the possibility of delivering care. Colleagues in Ukraine working to care for people with diabetes have given us disturbing accounts of the current situation. Ukrainian nationals living with diabetes are defending their country, both in the ranks of territorial defense and on the front lines. They are supplying first aid kits to the front lines, snacks to bomb shelters and new equipment to paediatric endocrinology departments. The Ukrainian Diabetic Federation, an IDF member, has greatly intensified its operations across the country and new regional diabetes organisations are being created.

"On February 24, at the beginning of the war, we experienced grief, tears, the deaths of our children, our elders, our women and our brave soldiers who have stood up to defend their country. In this difficult stage of our lives and the life of our beloved Ukraine, we matured, became wiser, stronger and more attentive to each other. People with diabetes were left alone with their huge burden until they united and helped each other. It was difficult to get access to insulin, test strips for a glucometer, but doctors and volunteers were able to finally regulate the supply for those in need. We are the power! Glory to Ukraine!" Alexander Galaev, director of the Odessa branch of UDF, UDF volunteer since 10 years.

In the aftermath of this war, the medical care structure will need to be rebuilt. Those forced to flee for their lives will need ongoing support in the countries where they seek refuge. We call on healthcare systems to act fast to make sure that refugees with diabetes receive the care they need and to help individuals to normalise their blood glucose to protect against the life-threatening and debilitating complications of diabetes.

Since the start of the crisis, IDF Transnational Member Direct Relief has mobilised its resources to support medical needs in the country as they become known. 

In the three months since the invasion of Ukraine by Russian forces on February 24, 2022, Direct Relief has emerged as one of the largest charitable providers of medical aid to the country, delivering more than 650 tons of medicines and supplies and providing over $14.7 million in direct financial assistance to other organizations in the region. The cash assistance has included direct payments for refugees to cover prescription medication costs, as well as operating funds for health facilities providing care in Ukraine. Aid provided includes 61,148 insulin vials and pens and 78,976 bottles of other diabetes medicines.

Direct relief Ukraine landscape

© Direct Relief

IDF will continue to monitor the crisis and collaborate with Direct Relief to fulfill medical needs as it unfolds. If you would like to support the efforts of Direct Relief, financial donations can be made here. (Click on “Direct my donation to” and select “Ukraine crisis”).

The IDF Europe Region has called on all its members to join the Connect Solidarity network to support Ukrainian refugees living with diabetes across Europe. In its first phase, the initiative aims to support IDF Europe Members that wish to help associations in countries neighbouring Ukraine with support, medicines, supplies, etc.  For more information, visit https://www.connectsolidarity.eu/

IDF expresses its gratitude to the agencies that have acted fast to deliver medical supplies and aid to support Ukrainian citizens, including IDF partners and members who responded quickly to provide relief.

Related links:

Date: March 31, 14:00-15:30 CEST

Time: 90 minutes

Obesity and T2D webinar landscape version 2 01

The impact of non-communicable diseases (NCDs) is at an all-time high. NCDs are estimated to cause 41 million deaths each year (71% of the global total), of which 15 million are premature. Despite Member States having agreed a set of voluntary targets to achieve by 2025, the 0% increase in diabetes and obesity target is catastrophically off track.

World Obesity’s Missing the Target report shines a spotlight on the rise in obesity levels around the world and highlights that all countries are worryingly off track to meet the 2025 global targets that they committed to, subsequently endangering the success of other NCD targets such as those related to diabetes. The IDF Diabetes Atlas 10th Edition reports a continued global increase in the prevalence of type 2 diabetes, which accounts for around 90% of all diabetes. It confirms type 2 diabetes as a significant global challenge to the health and well-being of individuals, families and societies.

In view of this, IDF and World Obesity Federation have jointly developed the policy brief “Obesity and type 2 diabetes: a joint approach to halt the rise". To mark its launch, IDF and WOF hosted an online event on Thursday 31st March to:

  • Highlight that we will only be able to halt the rise of type 2 diabetes if action on obesity is also prioritised.
  • Generate knowledge about the root causes of obesity and recognise that it is a risk factor for type 2 diabetes and other health conditions, requiring urgent action, both in the short- and long-term.
  • Emphasise the importance of adopting a system-wide approach if we are to successfully halt the rise of diet-related NCDs.
  • Advocate for people-centred care and ensure that people living with obesity, type 2 diabetes and other NCDs are included in the development and evaluation of interventions and guidelines.

Speakers included:

  • Prof Akhtar Hussain, IDF President-elect
  • Ms Johanna Ralston, WOF CEO
  • Dr Francesco Branca, WHO Nutrition for Growth Department
  • Prof Wannee Nitiyanant, Royal College of Physicians of Thailand
  • Prof Mike Lean, University of Glasgow
  • Ms Heather Koga, IDF Blue Circle Voice member from Zimbabwe

Download the agendathe speaker biographies and the slides

View the recording below:

If you have any questions about this webinar, please send them to This email address is being protected from spambots. You need JavaScript enabled to view it..

© 2022 International Diabetes Federation Disclaimer Privacy policy